Cynvenio Biosystems, Inc. Release: ClearID Breast Cancer Genomic Test Is Now Reimbursable Under Most Health Insurance Plans

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LOS ANGELES--(BUSINESS WIRE)--Cynvenio Biosystems, Inc. announced today that it will be accepting payment for its ClearID Breast Cancer test under most health insurance plans including Aetna, UnitedHealth Group, Cigna, Assurant, Blue Cross/Blue Shield, Humana, Kaiser Permanente and various Health Maintenance Organizations (HMO), with the exception of Medicaid.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC